Učitavanje...
Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?
BACKGROUND: National regulatory authorities (NRAs) make the decision to register a medicine based on an assessment of its benefits and risks and publicly available assessment reports are used as a tool to communicate the basis for the decision. The Universal Methodology for Benefit-Risk Assessment (...
Spremljeno u:
| Izdano u: | Front Pharmacol |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7313675/ https://ncbi.nlm.nih.gov/pubmed/32625087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00855 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|